These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25952)

  • 21. [The potentiating effect of a new alpha-adrenergic blocking agent (E-643) on the action of bronchodilators (author's transl)].
    Ishihara Y; Yotsumoto H; Sasaki K; Kudoh S; Kitamura S
    Kokyu To Junkan; 1978 Nov; 26(11):1095-9. PubMed ID: 31666
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacology and clinical application of alpha-blocking drugs (author's transl)].
    Weber S; Merillon JP; Motte G; Gourgon R
    Therapie; 1980; 35(6):665-76. PubMed ID: 6112802
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on diphenyl ether derivatives. VII. Synthesis of 3-chlorodibenz(b,g)(1,5)oxazocine derivatives (author's transl)].
    Tanaka S; Ogata Y
    Yakugaku Zasshi; 1973 Aug; 93(8):1003-7. PubMed ID: 4797470
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on diphenyl ether derivatives. VI. Synthesis of dibenz(b,g)(1,5)thiazocine oxide derivatives (author's transl)].
    Tanaka S; Watanabe H; Ogata Y
    Yakugaku Zasshi; 1973 Aug; 93(8):997-1002. PubMed ID: 4797490
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and adrenoreceptor blocking action of aziridinium ions derived from phenoxybenzamine and dibenamine.
    Henkel JG; Portoghese PS; Miller JW; Lewis P
    J Med Chem; 1976 Jan; 19(1):6-10. PubMed ID: 1536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the pharmacology of the alpha-receptor blocker BE 2254 (HEAT) (author's transl)].
    Heinz N; Hofferber E
    Arzneimittelforschung; 1980; 30(12):2135-9. PubMed ID: 6111325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemical Transformations of Diverse Biologically Active Resveratrol Analogs in Batch and Flow Reactors.
    Mlakić M; Perinić H; Vušak V; Horváth O; Sampedro D; Losantos R; Odak I; Škorić I
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optically active derivatives of imidazolines. alpha-Adrenergic blocking properties.
    Hsu FL; Hamada A; Booher ME; Fuder H; Patil PN; Miller DD
    J Med Chem; 1980 Nov; 23(11):1232-5. PubMed ID: 6109025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.
    Clifton JE; Collins I; Hallett P; Hartley D; Lunts LH; Wicks PD
    J Med Chem; 1982 Jun; 25(6):670-9. PubMed ID: 6124636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Syntheses of (+)-cytisine, (-)-kuraramine, (-)-isokuraramine, and (-)-jussiaeiine A.
    Honda T; Takahashi R; Namiki H
    J Org Chem; 2005 Jan; 70(2):499-504. PubMed ID: 15651792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alpha-adrenergic receptors (author's transl)].
    Hanoune J
    Rev Med Brux; 1981 Apr; 2(4):431-2. PubMed ID: 6117120
    [No Abstract]   [Full Text] [Related]  

  • 34. Ergoline derivatives. Note XIII (1) alpha-adrenergic blocking drugs.
    Bernardi L; Bosisio G; Elli C; Patelli B; Temperilli A; Arcari G; Glaesser HA
    Farmaco Sci; 1975 Oct; 30(10):789-801. PubMed ID: 241664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction between clonidine and alpha-blockers (author's transl)].
    Huchet AM; Chelly J; Schmitt H
    Nouv Presse Med; 1980 Feb; 9(9):613-4. PubMed ID: 6102376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol.
    Brizzi A; Brizzi V; Valoti M
    Farmaco; 2005 Feb; 60(2):105-11. PubMed ID: 15752469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
    Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
    Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Syntheses of 1-carboxy-1,2,3,4-tetrahydroisoquinoline derivatives, 6-carboxy-1,2,3,4,4a,5,6,10b-oxtahydrophenanthridine derivatives and 6-carboxy-dibenzo[b, d]pyran derivatives by phenolic cyclization (studies on the syntheses of heterocyclic compounds. DCLXIV) (author's transl)].
    Kametani T; Kigasawa K; Hiiragi M; Ishimaru H; Shiroyama K
    Yakugaku Zasshi; 1976 Aug; 96(8):1031-5. PubMed ID: 1035936
    [No Abstract]   [Full Text] [Related]  

  • 39. [Reactions of substituted sulfamides with formaldehyde derivatives (author's transl)].
    Dusemund J
    Arch Pharm (Weinheim); 1977 May; 310(5):404-9. PubMed ID: 559480
    [No Abstract]   [Full Text] [Related]  

  • 40. Total synthesis of (-)-galanthamine and (-)-lycoramine via catalytic asymmetric hydrogenation and intramolecular reductive Heck cyclization.
    Chen JQ; Xie JH; Bao DH; Liu S; Zhou QL
    Org Lett; 2012 Jun; 14(11):2714-7. PubMed ID: 22612349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.